Laurion Capital Management’s DexCom DXCM Stock Holding History

Laurion Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,800	Closed	-$5.44M	–	545
2023 Q4	$5.44M	Buy	43,800 +43,000	+5,375%	+$4.39M	0.05%	239
2023 Q3	$74.6K	Buy	+800	New	+$90.2K	﹤0.01%	454
2023 Q2	–	Sell	-637,000	Closed	-$74M	–	623
2023 Q1	$74M	Buy	+637,000	New	+$71.3M	0.5%	48
2022 Q4	–	Sell	-117,500	Closed	-$9.46M	–	450
2022 Q3	$9.46M	Buy	+117,500	New	+$9.95M	0.06%	194
2021 Q4	–	Sell	-200,000	Closed	-$27.3M	–	607
2021 Q3	$27.3M	Buy	+200,000	New	+$25.2M	0.12%	173
2020 Q4	–	Sell	-215,200	Closed	-$22.2M	–	709
2020 Q3	$22.2M	Buy	+215,200	New	+$22.5M	0.26%	94

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Laurion Capital Management's DXCM Position: Q4 2023 in Review

Laurion Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 16,954 shares — an estimated $1.73M sold.

Laurion Capital Management first reported a position in DXCM in Q2 2015 and held it in 9 quarters. The position peaked at $5.39M in Q2 2015. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Laurion Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Laurion Capital Management sold 16,954 DexCom shares in Q4 2023, an estimated $1.73M.
Laurion Capital Management first reported a position in DexCom in Q2 2015 and held it in 9 quarters.
Laurion Capital Management's DexCom position peaked at $5.39M in Q2 2015.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.